Vitamin E Prevents Side Effects of Chemotherapy
Thirty-one cancer patients receiving six courses of cisplatin, paclitaxel, or both of these drugs were randomly assigned to receive 600 IU/day of vitamin E or no vitamin E (control group) during chemotherapy. Neurotoxicity occurred in 25% of the patients in the vitamin E group and in 73.3% of those in the control group.
The results of the present study indicate that vitamin E supplementation can reduce the incidence and severity of chemotherapy-induced peripheral neuropathy.
Read more on this vitamin E chemotherapy study.












0 Comments:
Post a Comment
<< Home